您的位置: 首页 > 农业专利 > 详情页

BILAYER TABLET FORMULATIONS
专利权人:
AstraZeneca UK Limited;AstraZeneca AB
发明人:
Abebe, Admassu,Martin, Kyle,Patel, Jatin M.,Desai, Divyakant,Timmins, Peter
申请号:
AU2020202589
公开号:
AU2020202589A1
申请日:
2020.04.16
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
#$%^&*AU2020202589A120200507.pdf#####ABSTRACT The present invention relates to bilayer tablet formulations comprising metformin extended release (XR) or reduced mass metformin XR formulation as the first layer, an 5 SGLT2 inhibitor formulation as the second layer, and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with SGLT2 activity employing the bilayer tablet formulations.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充